A cure-rate model for Q-learning: estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients

DOI10.1002/BIMJ.201700181zbMATH Open1419.62412OpenAlexW2805002703WikidataQ88688541 ScholiaQ88688541MaRDI QIDQ4967115FDOQ4967115

Elizabeth F. Krakow, Stephen Spellman, Shomoita Alam, Mukta Arora, David A. Stephens, Mei-Jie Zhang, Erica E. M. Moodie, Brent R. Logan

Publication date: 2 July 2019

Published in: Biometrical Journal (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc6239975

Recommendations

• Q-learning with censored data
• Interactive model building for Q-learning
• Robust Q-learning
• Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer
• \(Q\)- and \(A\)-learning methods for estimating optimal dynamic treatment regimes

zbMATH Keywords

adaptive treatment strategysurvival dataQ-learningcure-ratedynamic treatment regime

Mathematics Subject Classification ID

Reliability and life testing (62N05) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cited In (2)

• On ``Reflections on the concept of optimality of single decision point treatment regimes
• Causal inference for oncology: past developments and current challenges

This page was built for publication: A cure-rate model for Q-learning: estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4967115)